| Issue Date | Title | Author(s) |
| 2020-08 | HSPGs glypican-1 and glypican-4 are human neuronal proteins characteristic of different neural phenotypes. | Oikari, LE; Yu, C; Okolicsanyi, RK; Avgan, N; Peall, IW; Griffiths, LR; Haupt, LM |
| 2020-01-01 | The kainate receptor antagonist UBP310 but not single deletion of GluK1, GluK2, or GluK3 subunits, inhibits MPTP-induced degeneration in the mouse midbrain | Stayte, S; Laloli, KJ; Rentsch, P; Lowth, A; Li, KM; Pickford, R; Vissel, B |
| 2020-02 | Targeting the cannabinoid receptor CB2 in a mouse model of l-dopa induced dyskinesia. | Rentsch, P; Stayte, S; Egan, T; Clark, I; Vissel, B |
| 2015-02 | Programming of formalin-induced nociception by neonatal LPS exposure: Maintenance by peripheral and central neuroimmune activity. | Zouikr, I; Ahmed, AF; Horvat, JC; Beagley, KW; Clifton, VL; Ray, A; Thorne, RF; Jarnicki, AG; Hansbro, PM; Hodgson, DM |
| 2015-10 | Early life programming of pain: Neuroimmune to endocrine symphony | Zouikr, I; James, MH; Campbell, EJ; Ahmed, AF; Horvat, JC; Hansbro, PM; Clifton, VL; Beagley, KW; Thorne, RF; Dayas, CV; Hodgson, DM |
| 2020-06 | Impact of acute stress on cortical electrical activity and cardiac autonomic coupling. | Chalmers, T; Maharaj, S; Lees, T; Lin, CT; Newton, P; Clifton-Bligh, R; McLachlan, CS; Gustin, SM; Lal, S |
| 2017-10-01 | Characterisation of Peptide5 systemic administration for treating traumatic spinal cord injured rats | Mao, Y; Nguyen, T; Tonkin, RS; Lees, JG; Warren, C; O’Carroll, SJ; Nicholson, LFB; Green, CR; Moalem-Taylor, G; Gorrie, CA |
| 2017-04-01 | Dissociation between complete hippocampal context memory formation and context fear acquisition | Leake, J; Zinn, R; Corbit, L; Vissel, B |
| 2016-10-01 | Correlation between adherence to antiepileptic drugs and quality of life in patients with epilepsy: A longitudinal study | Lin, CY; Chen, H; Pakpour, AH |
| 2020-08-13 | Robust Dopaminergic Differentiation and Enhanced LPS-Induced Neuroinflammatory Response in Serum-Deprived Human SH-SY5Y Cells: Implication for Parkinson's Disease. | Niaz, A; Karunia, J; Mandwie, M; Keay, KA; Musumeci, G; Al-Badri, G; Castorina, A |
